Clinical Trials

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

1 day ago
2 min

Clario invests in new technology to reduce translation times for clinical trials

For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.

Aug 5
2 min

Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.

Aug 3
3 min

IDRx raises $122 million to transform cancer treatment with precision combination therapies

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.

Jul 29
3 min

HempMy Pet and Tarleton University announce positive results of their study using CBD on horses

HempMy Pet, a division of HM Health, LLC, offers CBD-infused products for dogs, cats, and horses.

Jul 11
3 min

FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100

Inflammation is a key feature in the pathogenesis of ARDS and the investigational product (IP) ALT-100 is an anti-inflammatory therapeutic..

Jul 9
4 min

Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology

There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA

Jun 5
3 min

Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials

Imaging Endpoints is the world’s largest oncology-focused imaging CRO and has partnered with ImaginAb over the past decade.

May 14
7 min

Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS

We continue to push the boundaries of innovation with RADICAVA ORS, an orally administered option allowing patients flexibility...

May 7
2 min

Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories

May 4
3 min

Four pharma solution providers launch Norstella to provide faster patient access to therapies

By launching Norstella, we’re taking the next step toward ensuring tha.t all patients have access to the therapies that they need

Apr 15
4 min

With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.

Apr 7
2 min

ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS

"With the close of this funding we will continue the journey from concept to clinical use/"

Mar 26
3 min

Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform

Globally, liver cancers are the fourth most common cause of cancer-related death and ranked sixth in terms of annual incidence.

Mar 24
3 min

Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic

Sen-Jam and KVK Tech will complete their phase II clinical trials or their oral COVID-19 drug, to have a finished product in 9-12 months.

Mar 21
3 min

Triumvia Immunologics completes $100 million round for its T cell therapeutics

“Cell therapies have become an essential modality in the oncology therapeutic arsenal and a priority for many biopharma companies.

Mar 2
2 min

Alcami, the contract development and manufacturer adds formulation development laboratory

Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions

Feb 28
4 min

Algernon Pharmaceuticals starts chronic kidney disease research program

Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds.

$Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma$

Feb 19
2 min

Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma

Dizal has a portfolio of innovative therapies for the treatment of cancer, immunological diseases and chronic kidney diseases.

Feb 14
5 min

Otsuka and Sunovlon start Phase 3 trials for a treatment for biopolar depression

Bipolar disorder affects approximately 12.6 million individuals in the United States and an estimated 29 million people worldwide.

Feb 12
4 min

Orthox raises $12.5 million to begin clinical trials for knee cartilage repair

Orthox's technology, originating from Oxford University, is a revolutionary tissue scaffold based on fibroin, a tissue regenerative protein.